Johnson & Johnson stock PB Ratio (=5.2) is close to 5-year low of 4.92
The historical rank and industry rank for Johnson & Johnson's PB Ratio or its related term are showing as below:
JNJ'
s PB Ratio Range Over the Past 10 Years
Min: 3.37 Med: 5.46 Max: 6.93
Current: 5.14
During the past 13 years, Johnson & Johnson's highest PB Ratio was 6.93. The lowest was 3.37. And the median was 5.46.
JNJ's PB Ratio is ranked worse than 85.14% of 962
companies
in the Drug Manufacturers industry
Industry Median: 1.945
vs JNJ: 5.14
During the past 12 months, Johnson & Johnson's average Book Value Per Share Growth Rate was -2.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 5.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 6.40% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 1.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Johnson & Johnson was 23.40% per year. The lowest was -4.60% per year. And the median was 9.40% per year.
Back to Basics: PB Ratio
Johnson & Johnson PB Ratio Historical Data
The historical data trend for Johnson & Johnson's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Johnson & Johnson's PB Ratio
For the Drug Manufacturers - General subindustry, Johnson & Johnson's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Johnson & Johnson's PB Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's PB Ratio distribution charts can be found below:
* The bar in red indicates where Johnson & Johnson's PB Ratio falls into.
Johnson & Johnson PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Johnson & Johnson PB Ratio Related Terms
Thank you for viewing the detailed overview of Johnson & Johnson's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Johnson & Johnson (Johnson & Johnson) Business Description
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
JNJ has been successfully added to your 